Author

Evelien Schaafsma

Dartmouth College - Cited by 549

Biography

Dr. Evelien Schaafsma is an professor works at the Departments of Biochemistry and Molecular Biology, New York Medical College, Valhalla, NY 10595, USA and she also worked in the Department of Cell Biology and Anatomy, New York Medical College, Valhalla, NY 10595, USA.
Title
Cited by
Year
VISTA is a checkpoint regulator for naïve T cell quiescence and peripheral tolerance
MA ElTanbouly, Y Zhao, E Nowak, J Li, E Schaafsma, I Le Mercier, ...Science 367 (6475), eaay0524, 2020202
133
2020
VISTA: Coming of age as a multi-lineage immune checkpoint
MA ElTanbouly, E Schaafsma, RJ Noelle, JL LinesClinical & Experimental Immunology 200 (2), 120-130, 2020202
66
2020
Pan-cancer association of HLA gene expression with cancer prognosis and immunotherapy efficacy
E Schaafsma, CM Fugle, X Wang, C ChengBritish journal of cancer 125 (3), 422-432, 2021202
51
2021
Profibrotic activation of human macrophages in systemic sclerosis
R Bhandari, MS Ball, V Martyanov, D Popovich, E Schaafsma, S Han, ...Arthritis & Rheumatology 72 (7), 1160-1169, 2020202
37
2020
Impact of Oncotype DX testing on ER+ breast cancer treatment and survival in the first decade of use
E Schaafsma, B Zhang, M Schaafsma, CY Tong, L Zhang, C ChengBreast Cancer Research 23, 1-11, 2021202
30
2021
A leukocyte infiltration score defined by a gene signature predicts melanoma patient prognosis
Y Zhao, E Schaafsma, IP Gorlov, E Hernando, NE Thomas, R Shen, ...Molecular Cancer Research 17 (1), 109-119, 2019201
28
2019
VISTA: a target to manage the innate cytokine storm
MA ElTanbouly, Y Zhao, E Schaafsma, CM Burns, R Mabaera, C Cheng, ...Frontiers in immunology 11, 595950, 2021202
28
2021
Defining the signature of VISTA on myeloid cell chemokine responsiveness
TWK Broughton, MA ElTanbouly, E Schaafsma, J Deng, A Sarde, ...Frontiers in Immunology 10, 2641, 2019201
23
2019
VISTA re-programs macrophage biology through the combined regulation of tolerance and anti-inflammatory pathways
MA ElTanbouly, E Schaafsma, NC Smits, P Shah, C Cheng, C Burns, ...Frontiers in immunology 11, 580187, 2020202
22
2020
18
2020
An EGFR signature predicts cell line and patient sensitivity to multiple tyrosine kinase inhibitors
C Cheng, Y Zhao, E Schaafsma, YL Weng, C AmosInternational journal of cancer 147 (9), 2621-2633, 2020202
12
2020
B cell infiltration is highly associated with prognosis and an immune-infiltrated tumor microenvironment in neuroblastoma
E Schaafsma, C Jiang, C ChengJournal of cancer metastasis and treatment 7 (34), 2021202
9
2021
Application of open-access databases to determine functional connectivity between resveratrol-binding protein QR2 and colorectal carcinoma
BB Doonan, E Schaafsma, JT Pinto, JM Wu, T HsiehIn Vitro Cellular & Developmental Biology-Animal 53, 575-57, 2017201
8
2017
Computational STAT3 activity inference reveals its roles in the pancreatic tumor microenvironment
E Schaafsma, Y Yuan, Y Zhao, C ChengScientific Reports 9 (1), 1825, 2019201
7
2019
A TMPRSS2‐ERG gene signature predicts prognosis of patients with prostate adenocarcinoma
E Zhou, B Zhang, K Zhu, E Schaafsma, RD Kumar, C ChengClinical and Translational Medicine 10 (8), 2020202
6
2020
Predicting clinical outcomes of cancer patients with a p53 deficiency gene signature
E Schaafsma, EM Takacs, S Kaur, C Cheng, M KurokawaScientific reports 12 (1), 1317, 2022202
6
2022
MYC activity inference captures diverse mechanisms of aberrant MYC pathway activation in human cancers
E Schaafsma, Y Zhao, L Zhang, Y Li, C ChengMolecular Cancer Research 19 (3), 414-428, 2021202
5
2021
VISTA targeting of T-cell quiescence and myeloid suppression overcomes adaptive resistance
E Schaafsma, W Croteau, M ElTanbouly, EC Nowak, NC Smits, J Deng, ...Cancer Immunology Research 11 (1), 38-55, 2023202
4
2023
Applications of ENCODE data to systematic analyses via data integration
Y Zhao, E Schaafsma, C ChengCurrent opinion in systems biology 11, 57-64, 2018201
3
2018